Astellas Pharma Inc. Site Map
 
Home > Therapeutic Areas > Products > Healthcare Professionals > Catalog
   
Catalog

Astellas Pharma US is committed to providing physicians with the most up-to-date information about our products. To view current prescribing information and other detailed information about our products, please click on the links provided below.

Brand Name Generic Name
Adenocard®IV (adenosine) injection
Adenoscan® (adenosine) injection
AmBisome® (amphotericin B liposome) injection
Lexiscan® (regadenoson) injection
Mycamine® (micafungin sodium) injection
Prograf® (tacrolimus) capsules and injection
Protopic® (tacrolimus) ointment
SUMAVELTM DoseProTM (sumatriptan injection) Needle-free delivery system
Tarceva® (erlotinib) tablets
Vaprisol® (conivaptan hydrochloride injection) ampule* and premixed in 5% Dextrose in INTRAVIA® plastic container
VESIcare® (solifenacin succinate) tablets
VIBATIV® (Telavancin) for injection

On January 6, 2012, Astellas Pharma Inc. and Theravance, Inc. announced that Astellas has exercised its right to terminate the global License, Development and Commercialization Agreement for VIBATIV® (telavancin) for injection. The rights granted to Astellas ceased upon termination of the Agreement and Astellas has stopped promotional sales efforts.

    
Copyright © 2005 - 2009 Astellas Pharma US, Inc. Site Map  Privacy Policy  Legal Disclaimer  Contact Us